Investing in the Future of Healthcare
The Sitala team are pioneers in the race to develop drugs to halt the progression of inflammatory and degenerative diseases. Our work is grounded in robust scientific research and clinical validation, which underpins the potential impact, safety and efficacy of our novel therapies. By addressing unmet medical needs in both common and rare conditions, our drug pipeline is also aligned with significant market demand in order to achieve commercial success. Join a venture with a solid track record of hitting developmental milestones in a timely manner, together with a bold, clear vision for significant advancements in medicine. Join us in transforming the future of healthcare.
Forbion
Forbion is a leading venture capital firm that works closely with entrepreneurs to build life sciences companies that transform people’s lives.
Orbimed
OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.
Advent Life Sciences
Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA.
British Business Bank
British Business Bank is a government-owned development bank who work with a broad network of lenders, fund managers, and regional partners to deliver funding that helps smaller businesses grow and thrive.
Partner with us
Sitala is actively sourcing in-licensing and partnering opportunities. We welcome enquires and proposals aligned with our core mission to deliver next generation anti-inflammatory drugs to the clinic.